Fentanyl Pain Patch

On July 15, 2005, the FDA issued a Public Health Advisory warning of the potential danger of transdermal fentanyl patches in response to reports of deaths in patients using this potent narcotic medication for pain management - including the generic product manufactured by Mylan Laboratories.

The FDA is conducting an investigation into over 120 deaths associated with these patches. The Agency has been examining the circumstances of patient patch use to determine if the reported adverse events may be related to inappropriate use of the patch or factors related to the quality of the product.

It is possible that some patients may not be completely aware of the dangers of these potent narcotic drug products and the important recommendations regarding their safe use. If you are using a Fentanyl pain patch - whether the Duragesic brand or a generic medication from Mylan Laboratories, you should seek medical guidance immediately.

The following language is required pursuant to Rule 7.2, Alabama Rules of Professional Conduct. No representation is made that the quality of legal services to be performed is greater than the quality of legal services performed by other lawyers. This web site is designed for general information only. The information presented at this site should not be construed to be formal legal advice nor the formation of a lawyer/client relationship.

Free Case Review